I agree that the article is great. It is filled with enough detailed information that anyone reading it with an unbiased mind will get the picture. My question, however, is why can't some more mainline publisher be found to release it. I know little about the web site the article is on other than a quick look. I am afraid that the site will give those with a less than unbiased mind an excuse to ignore the content of the article. Please don't kill the messenger (me), I am just stating what seems too obvious to me. If there are those who have some agenda in not wanting leronimab to be given a chance, a more “neutral” publisher is needed to get around them. I do understand there is an oxymoron in the previous sentence so don't kill me over that.